Radiation Therapy for Pleuropulmonary Blastoma: A Case Report and Review of Literature

A. Ylanan , N. Cupino
{"title":"Radiation Therapy for Pleuropulmonary Blastoma: A Case Report and Review of Literature","authors":"A. Ylanan ,&nbsp;N. Cupino","doi":"10.1016/j.ijrobp.2024.11.058","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to (1) describe a case of pleuropulmonary blastoma (PPB), and (2) discuss the role of radiation therapy in PPB management through a review of existing literature.</div></div><div><h3>Methods</h3><div>We described a case of PPB and conducted a comprehensive search through PubMed, Scopus, Cochrane, and the Grey Literature Report databases. Data on the role of radiation therapy, particularly its timing and outcomes, were reviewed and synthesized.</div></div><div><h3>Results</h3><div>A 4-year-old female with recurrent respiratory symptoms was diagnosed with PPB. A month after complete excision of the thoracic tumor and right upper lobectomy, recurrence was observed. Despite adjuvant chemotherapy, there was disease progression. The patient underwent subtotal re-excision followed by radiation therapy, receiving 4500 cGy to the grossly apparent tumor and 3600 cGy to the postoperative tumor bed in 180 cGy fractions concurrently with chemotherapy. Significant tumor regression was observed post-radiation therapy, with no significant adverse effects. The patient remains well three years after treatment.</div></div><div><h3>Discussion</h3><div>The role of upfront radiation therapy for PPB is unclear. Although registry data suggest it has no impact on overall survival, it is often considered when surgical resection is incomplete or when tumors demonstrate chemotherapy resistance. Additionally, radiation therapy may be utilized in treating PPB metastases, including those to the brain. The good long-term control in our patient suggests that its role requires further exploration.</div></div><div><h3>Conclusion</h3><div>Integration of radiation therapy in a multimodal treatment approach for recurrent PPB yielded favorable outcomes, suggesting it is a viable option warranting further investigation.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e16"},"PeriodicalIF":6.4000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036320","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

This study aims to (1) describe a case of pleuropulmonary blastoma (PPB), and (2) discuss the role of radiation therapy in PPB management through a review of existing literature.

Methods

We described a case of PPB and conducted a comprehensive search through PubMed, Scopus, Cochrane, and the Grey Literature Report databases. Data on the role of radiation therapy, particularly its timing and outcomes, were reviewed and synthesized.

Results

A 4-year-old female with recurrent respiratory symptoms was diagnosed with PPB. A month after complete excision of the thoracic tumor and right upper lobectomy, recurrence was observed. Despite adjuvant chemotherapy, there was disease progression. The patient underwent subtotal re-excision followed by radiation therapy, receiving 4500 cGy to the grossly apparent tumor and 3600 cGy to the postoperative tumor bed in 180 cGy fractions concurrently with chemotherapy. Significant tumor regression was observed post-radiation therapy, with no significant adverse effects. The patient remains well three years after treatment.

Discussion

The role of upfront radiation therapy for PPB is unclear. Although registry data suggest it has no impact on overall survival, it is often considered when surgical resection is incomplete or when tumors demonstrate chemotherapy resistance. Additionally, radiation therapy may be utilized in treating PPB metastases, including those to the brain. The good long-term control in our patient suggests that its role requires further exploration.

Conclusion

Integration of radiation therapy in a multimodal treatment approach for recurrent PPB yielded favorable outcomes, suggesting it is a viable option warranting further investigation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiotherapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study. Concurrent and consolidative carboplatin plus nab-paclitaxel or paclitaxel in locally advanced NSCLC A multicenter, randomized clinical trial. The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer. A Dual Energy CT-Guided Intelligent Radiation Therapy Platform. Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1